Keyphrases
Cancer Patients
100%
In Cancer
100%
Vitamin K Antagonists
100%
Low Molecular Weight Heparin
100%
Venous Thromboembolism
100%
Confidence Interval
55%
Relative Risk
55%
Bleeding
44%
Major Bleeding
33%
Thrombosis Recurrence
33%
Venous Thrombosis
22%
Anticoagulant Therapy
22%
Non-majors
22%
Heparin Therapy
22%
Deep Vein Thrombosis
11%
Pulmonary Embolism
11%
High Mortality Rate
11%
Enfermedad
11%
Recurrent Venous Thromboembolism
11%
Propensity Score Matching
11%
Recurrent Pulmonary Embolism
11%
Recurrent Deep Vein Thrombosis
11%
Treatment Choice
11%
Propensity Matching
11%
Therapy Switch
11%
Matched Cohort Study
11%
Stent Thrombosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Venous Thromboembolism
100%
Antivitamin K
100%
Low Molecular Weight Heparin
100%
Recurrent Disease
44%
Bleeding
44%
Vein Thrombosis
33%
Anticoagulant Agent
22%
Lung Embolism
22%
Deep Vein Thrombosis
22%
Cohort Study
11%
Mortality Rate
11%
Embolism
11%
Nursing and Health Professions
Antivitamin K
100%
Venous Thromboembolism
100%
Low Molecular Weight Heparin
100%
Confidence Interval
55%
Recurrent Disease
44%
Bleeding
44%
Vein Thrombosis
33%
Lung Embolism
22%
Anticoagulant Therapy
22%
Deep Vein Thrombosis
22%
Propensity Score
11%
Malignant Neoplasm
11%
Mortality Rate
11%
Cohort Analysis
11%
Heparinization
11%
Embolism
11%
Medicine and Dentistry
Low Molecular Weight Heparin
100%
Vitamin K Antagonist
100%
Venous Thromboembolism
100%
Recurrent Disease
44%
Phlebothrombosis
33%
Major Bleeding
33%
Bleeding
22%
Anticoagulant Therapy
22%
Deep Vein Thrombosis
22%
Pulmonary Embolism
22%
Malignant Neoplasm
11%
Cohort Analysis
11%
Mortality Rate
11%
Embolism
11%
Heparinization
11%